Senescence Life Sciences launches supplement for improving cognitive performance

Source: Senescence Life Sciences website.
EDGE is vegan.

Singapore-based healthcare startup Senescence Life Sciences has come up with a vegan supplement to help enhance mental agility, optimise cognitive performance and sustain levels of intense focus.

Targeted at professionals, parents and health enthusiasts between 30 and 55 years, EDGE is formulated by neuroscientists and is based on natural ingredients which are clinically proven to support cognitive function and combat brain ageing over the long term. Key ingredients include ginseng and gotu kola (Centella Asiatica, also called the Asiatic pennywort). Gotu kola appears to be promising for various conditions, from wound healing to preventing seizures. This 2010 meta review notes that it can increase attention span, concentration and combat ageing. Ginseng has also shown promise in cognitive tests, such as with this 2012 experiment.

“With hectic urban lifestyles in a booming Asian economy, young professionals are more prone to the harmful effects of brain ageing than ever before. Often viewed as a concern for the elderly, research shows that brain ageing can occur as young as in your twenties. The birth of EDGE was fuelled by the rising need for an effective solution to help young professionals combat the mental struggles of modern-day working habits,” said Dr Shawn Watson, neuroscientist, founder and CEO, Senescence Life Sciences.

Dr Watson explained that EDGE is different from existing supplements which are positioned in the same space. “Many supplements may tout cognitive benefits and clinical research, but then bring to market low-quality products that are far less effective to those tested in the lab. This is the gap our company closes. Our products not only use clinical-grade ingredients, but are designed together with leading neuroscientists to maximise efficacy.  EDGE is the solution for those looking to maintain their brain’s peak performance so they can be faster, sharper and better at meeting the increasing demands of urban lifestyles.”

Manufactured under stringent conditions in a Health Canada, US-FDA approved and GMP-certified facility in Canada, EDGE consistently tests four to 100 times better than Health Canada’s minimum requirements. Senescence Life Sciences says that while some improvements in energy can be noticed after taking the product for as little as two weeks, the product is designed for long term use and significant benefits can be seen after three months.

Interested?

 Buy Edge. The product contains no animal ingredients. A month's supply costs S$80.

You may soon be able to enjoy KonaRed at a store near you

Source:
KonaRed
website.

KonaRed, a pioneer of the coffee fruit category and manufacturers of antioxidant juices and nutritional supplements* from the Hawaiian CoffeeBerry coffee fruit from Kona, Hawaii in the US, has provided an update on its international expansion.

Since entering Asia in July 2015, KonaRed products have hit the shelves of Japanese retailers such as Aeon Retail, Kinokuniya and Natural Lawson Stores. KonaRed has just added another 70 stores with Aeon Stores in Japan and continues to grow with Lawson, Japan's second largest convenience store chain.

KonaRed has also shipped its first order to South Korea and has more expansion planned in this region in the near future.

KonaRed's President and COO Kyle Redfield commented, "We are focused on making strong progress in our international efforts and creating brand awareness and visibility on a global scale. Asia is a large priority for us at the moment. Our recent expansion successes not only add to our immediate top line but also build a strong platform for long-term growth."

KonaRed, through a licensing agreement with FutureCeuticals, produces and markets a range of products that showcase the Hawaiian Coffee Fruit, including antioxidant-rich extracts and powders from the Hawaiian Coffee Fruit, which are used to produce KonaRed's ready to drink antioxidant juice, green tea, coconut water, on-the-go packs and 100% Hawaiian Coffee Fruit Powders. The company is also launching a line of 100% Kona Coffee products that will include the coffee fruit as well. 

*KonaRed products are sold online. The company will ship to Australia and New Zealand.

Vitamin D does not help you live longer

Despite claims that vitamin D could be the new cure-all, new research from the University of Cambridge which examined data from nearly 100 studies has shown that vitamin D supplementation, when administered alone, does not reduce mortality among older adults.
 
Previous research had observed that lower levels of vitamin D in the blood are associated with a number of different diseases, including multiple sclerosis, cancer and cardiovascular disease. As it was unclear whether vitamin D supplementation when given alone (that is, not adminstered together with other interventions such as calcium) would reduce the risk of deaths from various causes, researchers analysed the results of 73 observational cohort studies and 22 randomised trials of both naturally circulating vitamin D and supplements (either D2 or D3). 

The analysis reinforced the observational associations of lower levels of circulating vitamin D concentrations with deaths from cardiovascular, cancer, as well as other causes, but also found that vitamin D supplements in the trials, overall, did not reduce the risk of all-cause mortality significantly. However, when researchers looked deeper, they did find that vitamin D3 alone reduced mortality by 11%, and stress that additional research on healthy populations is needed.

The research was published in the British Medical Journal (BMJ), and conducted by an international team of researchers that was co-led by Dr Rajiv Chowdhury at the University of Cambridge’s Department of Public Health and Primary Care. 

Dr Chowdhury said: “Before any recommendation of widespread supplementations with vitamin D3, it is, however, essential that further clinical investigations are conducted into the optimal dosage and safety. 

"It will also be important to examine whether D2 or D3 alone may indeed have different effects on the risk of death in different populations since the current trials were essentially based in elderly high risk populations with a variety of baseline diseases and any beneficial effects on healthy general populations are not yet known."

Read the original press release here.